Skip to main content

Eugeni Bruguera Cortada

Institutions of which they are part

Senior researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca

Eugeni Bruguera Cortada

Institutions of which they are part

Senior researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca

Projects

An effectiveness and safety study of varenicline for smoking cessation in hospitalized patients with psychiatric disorders

IP: Eugeni Bruguera Cortada
Collaborators: -
Funding agency: Pfizer Inc
Funding: 90196.52
Reference: VARENICLINE_WI231379-PFIZER2017
Duration: 29/01/2018 - 01/04/2020

Related news

A large-scale study involving Vall d’Hebron confirms the genetic relatedness among 14 different psychiatric disorders and groups them into five new families, paving the way for new treatments targeting their shared underlying genetic causes

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

The study, conducted with more than 1,400 people with addictive disorders, delves into the biological mechanisms that connect mental health, life trajectory and educational opportunities.

Related professionals

Miguel Del Campo Casanelles

Miguel Del Campo Casanelles

Senior researcher
Genetics Medicine
Read more
Nuria Vallejo Camazón

Nuria Vallejo Camazón

Senior researcher
Cardiovascular Diseases
Read more
Vicente García-Patos Briones

Vicente García-Patos Briones

Head of group
Biomedical Research in Melanoma
Read more
Sara Bayarri Fresquet

Sara Bayarri Fresquet

Teaching Unit
Internal Strategy Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.